Immuno-oncology

The Pharmacy Times® Immuno-oncology Resource Center is a comprehensive resource for clinical news and expert insights on treatments that harness the body's immune system to fight cancer.

Latest News

Teresa Thakrar, PharmD, BCOP, of GlaxoSmithKline, discusses the latest developments in immunotherapies that treat blood cancers during a session at the 2023 NCODA International Spring Forum.
Immunotherapies Changing the Way Relapsed/Refractory Settings Are Managed

March 24th 2023

Since 2014, 10 immunotherapies have been approved by the FDA, including 6 CAR T-cell therapies and 4 BiTE therapies.

Immune Checkpoint Inhibitors Have Transformed Treatment Landscape for Resectable NSCLC
Immune Checkpoint Inhibitors Have Transformed Treatment Landscape for Resectable NSCLC

March 23rd 2023

Immunotherapies, PARP Inhibitors Show Promise in Early Stage, Triple-Negative Breast Cancers
Immunotherapies, PARP Inhibitors Show Promise in Early Stage, Triple-Negative Breast Cancers

March 23rd 2023

Novel Gelatin Biomaterial Could Improve 3D Models in Cancer Immunotherapy
Novel Gelatin Biomaterial Could Improve 3D Models in Cancer Immunotherapy

March 23rd 2023

Kevin Davies, PhD, executive editor of The CRISPR Journal and GEN Biotechnology, discusses the potential of CRISPR technology during the keynote address at the ACCC Annual Meeting & Cancer Center Business Summit in Washington, DC.
CRISPR Technology Has Cured Patients of Certain Genetic Diseases, But Not All Patients Can Receive It Due to Cost, Accessibility

March 10th 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.